SLP Fluency Disorders & Stuttering 2

Question 1

Which pharmacological agent has shown the most evidence in reducing stuttering frequency in clinical trials?

Accepted Answer

Pagoclone

Answer

Pagoclone, a partial GABA-A agonist, has shown the most promising results in randomized controlled trials for reducing stuttering.

Question 2

A client who stutters reports that his speech is fluent when whispering but disfluent during normal conversation. This phenomenon is best explained by:

Accepted Answer

Reduced auditory feedback monitoring during whispered speech

Answer

Whispering reduces the intensity of auditory feedback, which can temporarily disrupt the aberrant feedback loop believed to contribute to stuttering.

Question 3

The Lidcombe Program for preschool children relies primarily on which therapeutic principle?

Accepted Answer

Operant conditioning with verbal contingencies

Answer

The Lidcombe Program uses operant conditioning in which parents deliver verbal contingencies (praise for stutter-free speech, acknowledgment of stuttering) in natural settings.

Question 4

Neuroimaging studies in adults who stutter most consistently reveal:

Accepted Answer

Overactivation of right hemisphere motor areas and underactivation of left auditory cortex

Answer

Adults who stutter show overactivation of right hemisphere motor regions compensating for underactivation of the left auditory cortex and speech motor network.

Question 5

Which assessment tool provides a standardized measure of stuttering severity that includes both frequency and duration components?

Accepted Answer

Stuttering Severity Instrument (SSI-4)

Answer

The SSI-4 quantifies stuttering severity using frequency of disfluencies, duration of longest stutters, and physical concomitants to yield a composite severity score.

(SLP) Speech-Language Pathologist Certified Practice Test

(SLP) Speech-Language Pathologist Certified Practice Test

SLP Fluency Disorders & Stuttering 2